Captain T Cell

Captain T Cell develops first-in-class efficacy-enhanced T cell therapies for solid tumor patients that are lacking treatment options. One of the company’s most recent advances is the establishment of a novel allogeneic platform to enable off-the-shelf treatments of solid tumors. Captain T Cell is a spin-off from the Max Delbrück Center in Berlin, Germany.